Injective jumps 8.51% as buyers return after a breakout above resistance

Traders Union
All News
Crypto News
Injective jumps 8.51% today to $4.66

Highlights

Injective's breakout above key resistance has triggered a bullish reversal and renewed buying from traders, despite waning derivatives activity.
Spot market momentum and willingness to gain exposure remain strong, but falling volume and open interest signal declining wider participation.
Technicals show overbought conditions with price trading between $4.70 and $5.10 likely, favoring a consolidation or pullback unless fresh catalysts emerge.

Renewed buying emerges as bullish reversal meets fading derivatives

Injective recently broke above key resistance levels, with technical indicators confirming a bullish reversal that has sparked renewed buying interest among traders. This move reflects a heightened willingness to take on exposure as short-term momentum signals turn positive. However, derivatives data points to declining volume and open interest, suggesting that broader market participation is waning even as spot activity surges.

Overbought risks rise as bullish momentum overrides technical boundaries

On the technical front, INJ's price sits above the SMA-20 at $3.76, the SMA-50 at $3.31, and the SMA-200 at $4.47, with the Ichimoku Kijun at $3.96 now acting as immediate support. Intraday volatility remains high, as the session’s trading range spans from $4.52 to $4.76. Signal-wise, the MACD and ADX both flash "Buy" signals on the daily chart, and the Awesome Oscillator aligns with this momentum outlook. Contrasting with this, oscillators such as the RSI (78.42), CCI (209.20), BBP (0.78), and Stoch RSI (100) all register extreme overbought readings, flagging the potential for short-term mean reversion even as buying activity dominates.

Consolidation likely as overbought signals curb rally prospects

Over the next five sessions, the typical volatility band relative to current levels is expected between $4.70 and $5.10. The probability of further immediate gains is low, with a greater chance of a pullback following the recent surge and pronounced overbought signals. The baseline scenario sees INJ consolidating between recent highs and the Kijun support, trading sideways if momentum moderates. Should price break above $5.10, additional upside could be unlocked, likely requiring a new catalyst, while a move below $4.70 would increase the risk of a deeper correction as traders react to technical exhaustion.

Anton Kharitonov, analyst at Traders Union, sees Injective’s recent breakout above resistance as technically significant, but remains wary of the sustainability of this move. He notes that fading derivatives volume and extreme overbought readings suggest limited conviction behind the rally. Kharitonov believes the risk of a pullback or sideways phase is now elevated as momentum indicators flash caution. "Until we see broader participation and a reset of overbought conditions, I expect INJ to consolidate or retrace in the near term."

Earlier, analysts noted that Injective was experiencing strong upward momentum while also cautioning that overbought conditions could limit further gains. The latest price action and shifts in derivatives participation reinforce the view that, despite technical strength, traders should be alert for a near-term pullback if momentum fades or overbought pressures drive corrective activity.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.